Home Keryx Biopharmaceuticals Announces Results From Ferric Citrate Phase...
 

Keywords :   


Keryx Biopharmaceuticals Announces Results From Ferric Citrate Phase...

2014-11-15 20:32:22| Biotech - Topix.net

Keryx Biopharmaceuticals, Inc. today announced results from a 48-week Open Label Extension safety study in which Ferric Citrate demonstrated long-term safety and efficacy in dialysis-dependent chronic kidney disease patients with elevated serum phosphorus levels, or hyperphosphatemia. The OLE findings were presented as a late-breaking poster at the 2014 American Society of Nephrology's Kidney Week meeting in Philadelphia, PA.

Tags: results phase announces citrate

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.11Dr.
25.112BOX
25.11 Bianchi roma4
25.11PS3 CECH-2000A HDD1TB
25.11
25.11
25.11SUN FRAME B2 51.5×72.8cm
25.11 Jack Bunny
More »